SCHEMBL6279656

SCHEMBL6279656

Cc1cc(C)c(-n2nnnc2SCC(=O)Nc2ccccc2Cl)c(C)c1

nearest known ligand 0.67

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.67
ALDH1A1 P00352 9/20 0.58
LMNA P02545 6/20 0.58
USP2 O75604 2/20 0.58
ALOX15 P16050 1/20 0.58
HSD17B10 Q99714 1/20 0.58
SMN1; SMN2 Q16637 8/20 0.57
TDP1 Q9NUW8 2/20 0.55
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
GAA P10253 2/20 0.55
MAPT P10636 1/20 0.55
TSHR P16473 1/20 0.52
APOBEC3A P31941 1/20 0.52
APOBEC3G Q9HC16 1/20 0.52
POLB P06746 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6277778 0.87 SMN1; SMN2 (0.76) L3MBTL1ALDH1A1LMNAUSP2ALOX15
SCHEMBL6278105 0.85 ALDH1A1 (0.52) L3MBTL1ALDH1A1LMNAUSP2ALOX15
SCHEMBL6279592 0.84 ALDH1A1 (0.69) L3MBTL1ALDH1A1LMNAUSP2ALOX15
SCHEMBL6280684 0.84 PKM (0.55) L3MBTL1ALDH1A1LMNAUSP2ALOX15
SCHEMBL6269345 0.83 ALDH1A1 (0.50) L3MBTL1ALDH1A1LMNAUSP2ALOX15
SCHEMBL1702875 0.82 TDP1 (0.69) ALDH1A1LMNAUSP2ALOX15HSD17B10
SCHEMBL6280412 0.80 ALDH1A1 (0.56) L3MBTL1ALDH1A1LMNAUSP2SMN1; SMN2
SCHEMBL24209696 0.78 NPSR1 (0.67) L3MBTL1ALDH1A1LMNAUSP2SMN1; SMN2
SCHEMBL1702494 0.78 ALDH1A1 (0.64) L3MBTL1ALDH1A1LMNAHSD17B10SMN1; SMN2
SCHEMBL6276510 0.77 TDP1 (0.55) L3MBTL1ALDH1A1LMNAUSP2ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9566284-B2 Agents and methods for treating ischemic and other diseases NONO INC. (CA) 2017-02-14 US disclosed
WO-2005115147-A2 HIV REVERSE TRANSCRIPTASE INHIBITORS MERCK & CO., INC. (US) 2005-12-08 WO disclosed